Rising number of FDA approvals are driving the growth in Global Anti-Viral Drugs Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Anti-Viral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, m-RNA Synthesis Inhibitors, Integrase Inhibitors, Others) By Indication (Coronavirus Infection, HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others (Pneumonia, Flu))